CATALAYER NEWS

OKYO Pharma receives FDA feedback on phase 3 neuropathic pain trial

Source: Investing.com · 2026-07-08

Full article text is available in the Catalayer news terminal.

MORE FROM INVESTING.COM
Why is Tripadvisor stock sliding today?
2026-07-21
Samsung Biologics launches $1.46 billion bid for PolyPeptide
2026-07-19
Jordan has not ordered evacuation of Aqaba airport or seaport, gov’t spokesperson says
2026-07-19
Tesla stock: How much does an improved auto business matter?
2026-07-19
What’s next for the ECB? Key expectations for next week
2026-07-18
RELATED ON CATALAYER
Related Topics
Biotech & FDA News
RELATED MARKETS
Prediction Markets
New Rihanna Album before GTA VI?51%New Playboi Carti Album before GTA VI?50%Will Jesus Christ return before GTA VI?50%
Open Catalayer terminal for live tracking →